for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Sanofi Says Co, GSK To Support COVAX With 200 Mln Doses Of COVID-19 Vaccine

Oct 28 (Reuters) -

* SANOFI SAYS CO AND GSK TO SUPPORT COVAX WITH 200 MILLION DOSES OF ADJUVANTED, RECOMBINANT PROTEIN-BASED COVID-19 VACCINE

* SANOFI SAYS CO AND GSK HAVE SIGNED STATEMENT OF INTENT WITH GAVI, THE LEGAL ADMINISTRATOR OF THE COVAX FACILITY

* SANOFI SAYS CO, GSK INTEND TO MAKE AVAILABLE 200 MILLION DOSES OF ADJUVANTED RECOMBINANT PROTEIN-BASED COVID-19 VACCINE, IF APPROVED, TO COVAX FACILITY Source text for Eikon:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up